Literature DB >> 19271378

Antibiotic selection for MRSA: case presentations and review of the literature.

Matthew R Hanson1, Christina L Chung.   

Abstract

Infection with methicillin-resistant Staphylococcus aureus (MRSA) is a growing presence in both the community and hospital settings. Initially, MRSA was a difficult to treat infection isolated to hospitalized patients. With the introduction of vancomycin and other newer antibiotics, successful treatment of nosocomial, or hospital-acquired MRSA (HA-MRSA) has become commonplace. More recently, MRSA has evolved independently in each community. These community-acquired MRSA (CA-MRSA) strains initially had more limited resistance profiles, but selective pressures have broadened the resistance in many areas. Given the evolution in resistance among MRSA isolates, choosing an appropriate antibiotic therapy is challenging. Here the authors present 3 cases of HA- and CA-MRSA from an inner-city, tertiary care center and review recent literature with regards to antibiotic selection and administration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19271378

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  4 in total

Review 1.  Anti-virulence strategies to combat bacteria-mediated disease.

Authors:  David A Rasko; Vanessa Sperandio
Journal:  Nat Rev Drug Discov       Date:  2010-01-18       Impact factor: 84.694

2.  Fijimycins A-C, three antibacterial etamycin-class depsipeptides from a marine-derived Streptomyces sp.

Authors:  Peng Sun; Katherine N Maloney; Sang-Jip Nam; Nina M Haste; Ritesh Raju; William Aalbersberg; Paul R Jensen; Victor Nizet; Mary E Hensler; William Fenical
Journal:  Bioorg Med Chem       Date:  2011-06-26       Impact factor: 3.641

3.  Recombinant lysostaphin protects mice from methicillin-resistant Staphylococcus aureus pneumonia.

Authors:  Chen Chen; Huahao Fan; Yong Huang; Fan Peng; Hang Fan; Shoujun Yuan; Yigang Tong
Journal:  Biomed Res Int       Date:  2014-07-16       Impact factor: 3.411

4.  Curcumin protects mice from Staphylococcus aureus pneumonia by interfering with the self-assembly process of α-hemolysin.

Authors:  Jianfeng Wang; Xuan Zhou; Wenhua Li; Xuming Deng; Yanhong Deng; Xiaodi Niu
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.